Correction to: Probiotics and Antimicrobial Proteins (2018)
10.1007/s12602-018-9401-3
The original version of this article contained mistakes, and the authors would like to correct them. The correct details are given below:
On page 6, right column line 4, SIBO should read IBS-C.
Figure 4, the legend of panel (d) should read IBS-M(+) (n = 10).
Figure 5, the legend of panel (b) should read IBS-M(+) (n = 10).
Fig. 4.
Effect of treatment with the studied preparation of four probiotics on the components of the IBS Severity Scoring System. a, b Percent change of scoring for bowel satisfaction and for the effect of bowel function on daily life in relation to the absence or presence of small intestinal bacterial overgrowth (SIBO). c Percent change of scoring for bowel function satisfaction in relation to the presence of diarrhea predominant IBS (IBD-D). d Percent change of abdominal pain intensity in relation to the presence of mixed-type IBS (IBD-M). The p values of statistically significant comparisons are shown
Fig. 5.
Effect of treatment with the studied preparation of four probiotics on the stool form and on the days of work loss. a Rate of patients with normal stool in relation to the presence of constipation-predominant IBS (IBS-C). Normal stool is considered as any Bristol stool scale of 4 or 5. b Decrease of the days ofwork loss compared to the period before treatment in relation to the presence of mixed-type IBS (IBS-M). The p values of statistically significant comparisons are shown. CI. confidence interval
The authors apologize for potential issues raised by these mistakes.
Footnotes
The online version of the original article can be found at 10.1007/s12602-018-9401-3